Lyra Therapeutics Inc.

05/06/2024 | Press release | Distributed by Public on 05/06/2024 06:10

Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis